Tonix Pharmaceuticals Holding Corp at Tarsier Capital Management Spring Summit Transcript
Greetings, and welcome to the Tonix Pharmaceuticals Holding Corp. Spring Investor Summit webcast. It is now my pleasure to introduce your host, Seth Lederman, CEO of Tonix. Thank you, Mr. Lederman. You may begin.
Well, thank you very much for the introduction, and thank you all for participating in this webcast. And I'm grateful to the organizers for rapidly converting this to an online conference in wake of the COVID pandemic.
I'm Seth Lederman. I'm the CEO of Tonix. And slide 2 is our forward-looking statement, disclaimer, and Safe Harbor statement. I want to specifically point out that we filed our 10-K after market yesterday. So there's very current information about the company on the SEC website in our annual report.
Slide 3 is just a very brief summary of our lead programs. We have the TNX-1800 potential vaccine for COVID, and that's in the preclinical stage. It's a live virus vaccine designed from our horse virus vaccine platform, and it expresses a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
